NOP-1A Uses, Dosage, Side Effects and more
NOP-1A is under investigation in clinical trial NCT01198197 (PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A).
| Trade Name | NOP-1A |
| Generic | NOP-1A |
| Type | |
| Formula | C22H26F2N2O2S |
| Weight | Average: 420.52 Monoisotopic: 420.168305585 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
